Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators:	Groupe Hospitalier Pitie-Salpetriere Institut National de la Santé Et de la Recherche Médicale, France
Information provided by:	Groupe Hospitalier Pitie-Salpetriere
ClinicalTrials.gov Identifier:	NCT00289159

Purpose

To determine wether multimodal MRI (conventinal T1 and T2 sequences, diffusion, magnetization transfer, spectroscopy) is reproducible; to follow up a cohort of patients with early remmittent MS after treatment with interferon.

Condition	Phase
Multiple Sclerosis	Phase IV

MedlinePlus related topics: Multiple Sclerosis

U.S. FDA Resources

Study Type:	Observational
Study Design:	Longitudinal, Defined Population, Prospective Study
Official Title:	Follow Up by Multimodal MRI of a Cohort of Patients With Early Remitting Multiple Sclerosis (REPROMMS Study).

Eligibility

Ages Eligible for Study:	18 Years to 50 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

MS patients according to Poser's criteria
Remitting evolution (less than two years of evolution)
Aged 18-50
Immunomodulatory treatment indicated

Exclusion Criteria:

Unable to perform MRI

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00289159

Sponsors and Collaborators

Groupe Hospitalier Pitie-Salpetriere

Institut National de la Santé Et de la Recherche Médicale, France

Investigators

Principal Investigator:

Ayman Tourbah, MD, PhD

AP-HP

More Information

Study ID Numbers:	RBM0110
Study First Received:	February 8, 2006
Last Updated:	February 8, 2006
ClinicalTrials.gov Identifier:	NCT00289159
Health Authority:	France: Ministry of Health

Keywords provided by Groupe Hospitalier Pitie-Salpetriere:

aged 18-50
remitting evolution
less than two years of evolution
MS patients

Study placed in the following topic categories:

Autoimmune Diseases
Multiple Sclerosis
Demyelinating Diseases
Demyelinating Autoimmune Diseases, CNS

Demyelinating diseases
Sclerosis
Autoimmune Diseases of the Nervous System

Additional relevant MeSH terms:

Pathologic Processes
Immune System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009